Careers  |  Sign In  |  Register

Latest in Internal Medicine

According to Reuters, tobacco companies such as Philip Morris International and Marlboro Inc. have now brought scientists in-house to help produce e-cigarettes that could potentially reduce the risk of diseases associated with smoking. If these industries can succeed with their goals, most likely that will...
Edmond J. LaVoie, PhD, Professor and Chair of the Department of Medicinal Chemistry at Rutgers University, discusses the potential of a new antibiotic to combat the increasing problems of antibiotic resistance. TAXIS Pharmaceuticals has identified a new agent, labeled TXA-709, that has a unique mechanism of...
According to CBS News, new experimental drugs to treat migraines have shown efficacy in test trials. Migraines affect approximately 36 million americans and can be severely debilitating. The drug works by reducing the level of calcitonin gene related peptide (CGRP) by utilizing monoclonal antibodies to CGRP....